Society for Clinical Research Sites

INC Research/inVentiv Health honored with SRCS Eagle Award

Wednesday, October 11, 2017

INC Research/inVentiv Health, the only fully integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract Commercial Organization), announced that it was awarded the 2017 Society for Clinical Research Sites (SCRS) Eagle Award in the CRO category during the SCRS Annual Global Site Solutions Summit held October 6-8 in Boca Raton, Florida. The award recognizes the CRO that best exemplifies outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships.

[Read More]

A critical need for timely site payments

Monday, August 28, 2017

The Pulse on Site Success by Christophe Berthoux

Research sites across the globe likely have felt the effects of delayed payments, inconsistent payment amounts and lack of explanation regarding what the payment was for. In a 2016 survey of Investigators conducted by DrugDev, getting paid “on time” was one of the top two burdens reported by sites. Receiving untimely payments not only produces financial stress to the site, it often leads to additional administrative load placed on staff members who must allocate resources to track down payments and deal with discrepancies.

[Read More]

Three Questions: Norman Goldfarb, MAGI

Monday, May 15, 2017

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Suz Redfearn spoke with Norman Goldfarb, chairman of Model Agreements & Guidelines International (MAGI), an organization that has spent a decade promoting the standardization of clinical trial agreements (CTAs) and contract templates that both sites and CROs or sponsors can use to speed study startup. Goldfarb is also editor of The Journal of Clinical Research Best Practices, and managing director of First Clinical Research. In April, the Association of Clinical Research Professionals gave Goldfarb their award for innovation for the MAGI CTA initiative.

[Read More]

PSI, INC, Chiltern take top site ratings

Saturday, April 1, 2017

Investigators report their working relationships with CROs have become more effective during the past two years, according to a new CenterWatch survey, and nearly half said overall CRO performance, for the first time, matches that of sponsor companies.

[Read More]

The Plight of the Site

Wednesday, March 1, 2017

Several months ago, Christine Pierre and I discussed the myriad burdens sites face as clinical research becomes ever more complex. We agreed that Clinical Ink and the Society for Clinical Research Sites (SCRS) shared the same desire to educate the industry about what I termed “the plight of the site.” To better understand how sites actually conduct research, Clinical Ink, SCRS and CenterWatch partnered to develop a comprehensive survey of site activities related to that critical moment in a clinical trial—the patient visit.

[Read More]

The need for—and barriers to—adopting eSource

Wednesday, February 15, 2017

Electronic data collection responsibility borne by investigative sites to support each clinical trial is onerous, with little to no relief in sight. In many instances, these responsibilities are being managed at the same time that paper data collection processes are prevalent.

[Read More]

Three Questions: Jeff Pohlig, Compass Research

Monday, February 6, 2017

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Karyn Korieth spoke with Jeff Pohlig, vice president, U.S. Operations for Compass Research, which is part of the Bioclinica Research Network. Compass Research, which has three locations in Central Florida, was a finalist for the Society for Clinical Research Sites’ 2016 Site Patient Recruitment Innovation Award (SPRIA), which recognizes research sites that have developed and implemented innovative patient recruitment programs.

[Read More]

Reassessing site engagement activities

Wednesday, February 1, 2017

Drug development sponsors and CROs increasingly recognize the importance of investigative sites having a stronger, more respected voice in the clinical research community and have begun adopting initiatives designed to incorporate site viewpoints into improving clinical development processes.

[Read More]